These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Some pharmacological actions of methyl-substituted piperidino ethylguanidines (author's transl)]. Chen W; Zhai S; Ting K Yao Xue Xue Bao; 1979; 14(3):161-6. PubMed ID: 506721 [No Abstract] [Full Text] [Related]
4. Pharmacological properties of a new beta-receptor blocking agent. Clark B; Saameli K Triangle; 1970; 9(8):300-8. PubMed ID: 4397310 [No Abstract] [Full Text] [Related]
6. Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent. Alps BJ; Johnson ES; Wilson AB Br J Pharmacol; 1970 Sep; 40(1):151P-152P. PubMed ID: 4395083 [No Abstract] [Full Text] [Related]
7. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound]. Kroneberg G; Schlossmann K; Stoepel K Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784 [No Abstract] [Full Text] [Related]
8. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent. Bapat SK; Dhawan BN; Srimal RC Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115 [No Abstract] [Full Text] [Related]
9. Autonomic blocking properties of Wy 21901. Alps BJ; Hill M; Johnson ES; Wilson AB Br J Pharmacol; 1970 Sep; 40(1):153P. PubMed ID: 4395084 [No Abstract] [Full Text] [Related]
10. [Pharmacological studies on DL-1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide, a new antitumor agent (author's transl)]. Yamada K; Koshiura R; Miyamoto K; Sanae F Yakugaku Zasshi; 1980 Mar; 100(3):347-54. PubMed ID: 7381688 [No Abstract] [Full Text] [Related]
11. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent]. Brunner H; Hedwall PR; Meier M Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373 [No Abstract] [Full Text] [Related]
12. On the mechanism of action of an adrenergic blocking guanidine (CG8345-Go). Kaul CL; Grewal RS Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):192-204. PubMed ID: 7283548 [TBL] [Abstract][Full Text] [Related]
13. The action of protriptyline on peripheral autonomic function. Cairncross KD; McCulloch MW; Mitchelson F J Pharmacol Exp Ther; 1965 Sep; 149(3):365-72. PubMed ID: 5848047 [No Abstract] [Full Text] [Related]
14. [Pharmacodynamic study of an alpha adrenolytic compound: acetoxy-thymoxy-ethyl-dimethylamine. II. Pharmacological study]. Mercier J; Canellas J; Roquebert J Therapie; 1971; 26(4):785-94. PubMed ID: 4399130 [No Abstract] [Full Text] [Related]
15. [Pharmacological properties of a series of sympatholytics--guanidine derivatives]. Spivakova RP Farmakol Toksikol; 1971; 34(6):650-3. PubMed ID: 5139778 [No Abstract] [Full Text] [Related]
16. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678). Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490 [No Abstract] [Full Text] [Related]
17. Guanidine and amidoxime derivatives of some diphenylmethyl and related tricyclic ethers. van der Stelt C; Hofman PS; Funcke AB; Nauta WT Arzneimittelforschung; 1967 Nov; 17(11):1446-9. PubMed ID: 5632166 [No Abstract] [Full Text] [Related]